Environmental conditions and their impact on host immunity
Environmental conditions and their impact on host immunity
批准号:
8588929
负责人:
Herman F Staats
金额:
$7.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-12-01 至 2014-11-30
关键词:
AdjuvantAllergicAllergic DiseaseAllergic ReactionAluminumAnaphylaxisAntibioticsAntigensAreaAsthmaBacterial InfectionsBasophilsCD4 Positive T LymphocytesCessation of lifeChildDeveloped CountriesDeveloping CountriesDevelopmentDiseaseEczemaElementsEndotoxinsEnvironmentEnvironmental Risk FactorEpidemiologyEquilibriumExposure toFarming environmentFood HypersensitivityFoundationsFutureGoalsHay feverHelper-Inducer T-LymphocyteHospitalizationHouse miceHumanHygieneHypersensitivityIgEImmuneImmune systemImmunityImmunizationIncidenceInfectionInterferonsInterleukin-12Interleukin-4LifeMeasuresMediatingModelingMonitorMusPeanuts - dietaryPhenotypePredispositionPrevalencePreventionProductionReactionResearchRiskRisk FactorsSeveritiesSignal TransductionSodium ChlorideUnited StatesVaccinatedVaccinationVaccine AdjuvantVaccinesVirus Diseasescytokinedesignenvironmental allergyexperienceimprovedmast cellmouse modelnovelpreventpublic health relevanceresearch studyresponsetoll-like receptor 4
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Industrialized countries have experienced an increase in Th2-dependent, IgE- mediated allergic diseases such as food allergy, asthma, and hay fever. Food allergy causes 30,000 cases of anaphylaxis and 200 deaths annually in the United States alone. The cause for the escalation in allergic disease remains unknown. In recent decades, potential risk factors such as improved living conditions and the use of aluminum (alum)-adjuvanted vaccines have been proposed as being associated with the increased prevalence of allergic disease. It is our hypothesis that the cumulative effect of the allergy risk factors creates a Th2-biased immune environment in the host that predisposes the host to the development of allergy. The goal of this proposal is to utilize a mouse model to determine if the presence of proposed allergy risk factors including low LPS environment and exposure to alum-adjuvanted vaccines influences the phenotype of the host systemic and mucosal immune system. Additionally, we will determine if the presence of these allergy risk factors influences the development of allergic sensitization to peanut. To achieve this goal, mice will be maintained in standard mouse housing conditions or in conditions designed to mimic modern, industrialized countries that have experienced increased allergic diseases. The "modern" conditions will include low endotoxin, exposure to alum-adjuvanted immunizations or low endotoxin combined with alum-adjuvanted vaccines. All mice will be sensitized to peanut antigens. Upon completion of sensitization mice will be challenged with peanut and monitored for the incidence and severity of an allergic reaction. The experiments proposed in this application will provide the foundation for future mechanistic studies to define environmental factors that contribute to the increased prevalence of food allergy and provide a model to evaluate novel therapies for their ability to prevent the induction of peanut food allergy.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Developing RNA Vaccines to Treat Peanut Hypersensitivity
-
批准号:10570339
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2023
-
负责人:Herman F Staats
-
依托单位:
Mucosal vaccination to protect against HIV-1 infection at mucosal sites
-
批准号:8410154
-
项目类别:
-
资助金额:$49.19万
-
财政年份:2012
-
负责人:Herman F Staats
-
依托单位:
Mucosal vaccination to protect against HIV-1 infection at mucosal sites
-
批准号:8685120
-
项目类别:
-
资助金额:$60.73万
-
财政年份:2012
-
负责人:Herman F Staats
-
依托单位:
Evaluation of the nasal adjuvant activity of angiotensin peptide Ang-(1-7)
-
批准号:8431730
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2012
-
负责人:Herman F Staats
-
依托单位:
Evaluation of the nasal adjuvant activity of angiotensin peptide Ang-(1-7)
-
批准号:8245668
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2012
-
负责人:Herman F Staats
-
依托单位:
Mucosal vaccination to protect against HIV-1 infection at mucosal sites
-
批准号:8500195
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2012
-
负责人:Herman F Staats
-
依托单位:
Environmental conditions and their impact on host immunity
-
批准号:8431837
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2012
-
负责人:Herman F Staats
-
依托单位:
EVALUATION OF A PRIME-BOOST VACCINE FOR AEROSOL RICIN EXPOSURE IN NHPS
-
批准号:8358152
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2011
-
负责人:Herman F Staats
-
依托单位:
Nasal Vaccines: Mode of Action, Composition & Delivery
-
批准号:8069023
-
项目类别:
-
资助金额:$13.76万
-
财政年份:2010
-
负责人:Herman F Staats
-
依托单位:
Development of Efficacious and Stable Nasal Vaccine Formulations
-
批准号:7802325
-
项目类别:
-
资助金额:$73.31万
-
财政年份:2009
-
负责人:Herman F Staats
-
依托单位:
Development of Efficacious and Stable Nasal Vaccine Formulations
-
批准号:8121324
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2009
-
负责人:Herman F Staats
-
依托单位:
Development of Efficacious and Stable Nasal Vaccine Formulations
-
批准号:8291355
-
项目类别:
-
资助金额:$78.72万
-
财政年份:2009
-
负责人:Herman F Staats
-
依托单位:
Development of Efficacious and Stable Nasal Vaccine Formulations
-
批准号:8485519
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2009
-
负责人:Herman F Staats
-
依托单位:
Development of Efficacious and Stable Nasal Vaccine Formulations
-
批准号:8098770
-
项目类别:
-
资助金额:$79.46万
-
财政年份:2009
-
负责人:Herman F Staats
-
依托单位:
Development of Efficacious and Stable Nasal Vaccine Formulations
-
批准号:7644601
-
项目类别:
-
资助金额:$75.21万
-
财政年份:2009
-
负责人:Herman F Staats
-
依托单位:
DISTRIBUTION AND CLEARANCE OF NASAL VACCINES
-
批准号:7726125
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2008
-
负责人:Herman F Staats
-
依托单位:
DISTRIBUTION AND CLEARANCE OF NASAL VACCINES
-
批准号:7601152
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:Herman F Staats
-
依托单位:
DISTRIBUTION AND CLEARANCE OF NASAL VACCINES
-
批准号:7358293
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2006
-
负责人:Herman F Staats
-
依托单位:
Nasal Vaccines: Mode of Action, Composition & Delivery
-
批准号:7558981
-
项目类别:
-
资助金额:$45.53万
-
财政年份:2006
-
负责人:Herman F Staats
-
依托单位:
Nasal Vaccines: Mode of Action, Composition & Delivery
-
批准号:7177539
-
项目类别:
-
资助金额:$49.35万
-
财政年份:2006
-
负责人:Herman F Staats
-
依托单位:
海外基金